Lanean...
Development of Therapeutic Vaccines for Ovarian Cancer
Ovarian cancer remains the deadliest of all gynecologic malignancies. Our expanding knowledge of ovarian cancer immunology has allowed the development of therapies that generate systemic anti-tumor immune responses. Current immunotherapeutic strategies include immune checkpoint blockade, cellular th...
Gorde:
Egile Nagusiak: | , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
MDPI AG
2020-11-01
|
Saila: | Vaccines |
Gaiak: | |
Sarrera elektronikoa: | https://www.mdpi.com/2076-393X/8/4/657 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|